Cargando…
Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome
Dementia in Alzheimer’s disease (DAD) is more common in adults with Down syndrome (DS), with characteristically an earlier onset. The treatment of DAD is not too dissimilar in the general population and in people with intellectual disabilities. However, the underlying intellectual disability can mak...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053091/ https://www.ncbi.nlm.nih.gov/pubmed/30050371 http://dx.doi.org/10.2147/DNND.S91754 |
_version_ | 1783340755704610816 |
---|---|
author | Prasher, Vee P Mahmood, Hassan Mitra, Madhumanti |
author_facet | Prasher, Vee P Mahmood, Hassan Mitra, Madhumanti |
author_sort | Prasher, Vee P |
collection | PubMed |
description | Dementia in Alzheimer’s disease (DAD) is more common in adults with Down syndrome (DS), with characteristically an earlier onset. The treatment of DAD is not too dissimilar in the general population and in people with intellectual disabilities. However, the underlying intellectual disability can make the management of DAD more challenging in older adults with DS. This literature review aimed to look at the management of DAD in people with DS. The management of dementia is holistic. This includes treating reversible factors, aiming to slow the cognitive decline, psychological therapies, ensuring that the environment is appropriate, and use of psychotropic medication when necessary to manage behavioral problems, psychotic symptoms, depressive symptoms, and sleep difficulty. Antidementia medications have a role to play but remain limited. The management of DAD in the DS population can be at times challenging, but good clinical practice should involve accurate diagnosis of dementia, treating any reversible additional factors, consideration of psychological and behavioral management, use of antidementia medication, and a multidisciplinary team approach. |
format | Online Article Text |
id | pubmed-6053091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60530912018-07-26 Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome Prasher, Vee P Mahmood, Hassan Mitra, Madhumanti Degener Neurol Neuromuscul Dis Review Dementia in Alzheimer’s disease (DAD) is more common in adults with Down syndrome (DS), with characteristically an earlier onset. The treatment of DAD is not too dissimilar in the general population and in people with intellectual disabilities. However, the underlying intellectual disability can make the management of DAD more challenging in older adults with DS. This literature review aimed to look at the management of DAD in people with DS. The management of dementia is holistic. This includes treating reversible factors, aiming to slow the cognitive decline, psychological therapies, ensuring that the environment is appropriate, and use of psychotropic medication when necessary to manage behavioral problems, psychotic symptoms, depressive symptoms, and sleep difficulty. Antidementia medications have a role to play but remain limited. The management of DAD in the DS population can be at times challenging, but good clinical practice should involve accurate diagnosis of dementia, treating any reversible additional factors, consideration of psychological and behavioral management, use of antidementia medication, and a multidisciplinary team approach. Dove Medical Press 2016-09-20 /pmc/articles/PMC6053091/ /pubmed/30050371 http://dx.doi.org/10.2147/DNND.S91754 Text en © 2016 Prasher et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Prasher, Vee P Mahmood, Hassan Mitra, Madhumanti Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome |
title | Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome |
title_full | Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome |
title_fullStr | Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome |
title_full_unstemmed | Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome |
title_short | Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome |
title_sort | challenges faced in managing dementia in alzheimer’s disease in patients with down syndrome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053091/ https://www.ncbi.nlm.nih.gov/pubmed/30050371 http://dx.doi.org/10.2147/DNND.S91754 |
work_keys_str_mv | AT prasherveep challengesfacedinmanagingdementiainalzheimersdiseaseinpatientswithdownsyndrome AT mahmoodhassan challengesfacedinmanagingdementiainalzheimersdiseaseinpatientswithdownsyndrome AT mitramadhumanti challengesfacedinmanagingdementiainalzheimersdiseaseinpatientswithdownsyndrome |